This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, Y. P. Articles by Luo, J.-H. Search for Related Content PubMed PubMed Citation Articles by Yu, Y. P. Articles by Luo, J.-H. Social Bookmarking                            What's this?

Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy

From the Department of Pathology and Urology, University of Pittsburgh School of Medicine, and Biostatistics Center, University of Pittsburgh Cancer Institute and Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA

Address reprint requests to Jian-Hua Luo, MD, University of Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh, 3550 Terrace St, Pittsburgh, PA 15261; e-mail: luoj{at}msx.upmc.edu

PURPOSE: The incidence of prostate cancer is frequent, occurring in almost one-third of men older than 45 years. Only a fraction of the cases reach the stages displaying clinical significance. Despite the advances in our understanding of prostate carcinogenesis and disease progression, our knowledge of this disease is still fragmented. Identification of the genes and patterns of gene expression will provide a more cohesive picture of prostate cancer biology.

PATIENTS AND METHODS: In this study, we performed a comprehensive gene expression analysis on 152 human samples including prostate cancer tissues, prostate tissues adjacent to tumor, and organ donor prostate tissues, obtained from men of various ages, using the Affymetrix (Santa Clara, CA) U95a, U95b, and U95c chip sets (37,777 genes and expression sequence tags).

RESULTS: Our results confirm an alteration of gene expression in prostate cancer when comparing with nontumor adjacent prostate tissues. However, our study also indicates that the gene expression pattern in tissues adjacent to cancer is so substantially altered that it resembles a cancer field effect.

CONCLUSION: We also found that gene expression patterns can be used to predict the aggressiveness of prostate cancer using a novel model.

Supported by grants 1UO1CA88110-01 (G.M.) and R01 CA098249 (J.H.L.) from the National Cancer Institute.

Authors’ disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. E. Brennan, Y. Kuwano, N. Alkharouf, P. J. Blackshear, M. Gorospe, and G. M. Wilson The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis Cancer Res., June 15, 2009; 69(12): 5168 - 5176. [Abstract] [Full Text] [PDF]

				M. Lupien and M. Brown Cistromics of hormone-dependent cancer Endocr. Relat. Cancer, June 1, 2009; 16(2): 381 - 389. [Abstract] [Full Text] [PDF]

				G. J. Kelloff, P. Choyke, D. S. Coffey, and for The Prostate Cancer Imaging Working Group Challenges in Clinical Prostate Cancer: Role of Imaging Am. J. Roentgenol., June 1, 2009; 192(6): 1455 - 1470. [Abstract] [Full Text] [PDF]

				G. Wang, S. Haile, B. Comuzzi, A. H. Tien, J. Wang, T. M.K. Yong, A. E. Jelescu-Bodos, N. Blaszczyk, R. L. Vessella, B. A. Masri, et al. Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression Cancer Res., April 15, 2009; 69(8): 3433 - 3442. [Abstract] [Full Text] [PDF]

				G. Monami, V. Emiliozzi, A. Bitto, F. Lovat, S.-Q. Xu, S. Goldoni, M. Fassan, G. Serrero, L. G. Gomella, R. Baffa, et al. Proepithelin Regulates Prostate Cancer Cell Biology by Promoting Cell Growth, Migration, and Anchorage-Independent Growth Am. J. Pathol., March 1, 2009; 174(3): 1037 - 1047. [Abstract] [Full Text] [PDF]

				K. D. Sorensen, P. J. Wild, A. Mortezavi, K. Adolf, N. Torring, S. Heeboll, B. P. Ulhoi, P. Ottosen, T. Sulser, T. Hermanns, et al. Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy Clin. Cancer Res., February 15, 2009; 15(4): 1400 - 1410. [Abstract] [Full Text] [PDF]

				J. A. Koziol, A. C. Feng, Z. Jia, Y. Wang, S. Goodison, M. McClelland, and D. Mercola The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis Bioinformatics, January 1, 2009; 25(1): 54 - 60. [Abstract] [Full Text] [PDF]

				Y. Zhang, D. Linn, Z. Liu, J. Melamed, F. Tavora, C. Y. Young, A. M. Burger, and A. W. Hamburger EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance Mol. Cancer Ther., October 1, 2008; 7(10): 3176 - 3186. [Abstract] [Full Text] [PDF]

				E. N. Gal-Yam, G. Egger, L. Iniguez, H. Holster, S. Einarsson, X. Zhang, J. C. Lin, G. Liang, P. A. Jones, and A. Tanay Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line PNAS, September 2, 2008; 105(35): 12979 - 12984. [Abstract] [Full Text] [PDF]

				J. Yan, H. Erdem, R. Li, Y. Cai, G. Ayala, M. Ittmann, L.-y. Yu-Lee, S. Y. Tsai, and M.-J. Tsai Steroid Receptor Coactivator-3/AIB1 Promotes Cell Migration and Invasiveness through Focal Adhesion Turnover and Matrix Metalloproteinase Expression Cancer Res., July 1, 2008; 68(13): 5460 - 5468. [Abstract] [Full Text] [PDF]

				L. G. Wang, E. M. Johnson, Y. Kinoshita, J. S. Babb, M. T. Buckley, L. F. Liebes, J. Melamed, X.-M. Liu, R. Kurek, L. Ossowski, et al. Androgen Receptor Overexpression in Prostate Cancer Linked to Pur{alpha} Loss from a Novel Repressor Complex Cancer Res., April 15, 2008; 68(8): 2678 - 2688. [Abstract] [Full Text] [PDF]

				C. D. McCabe, D. D. Spyropoulos, D. Martin, and C. S. Moreno Genome-Wide Analysis of the Homeobox C6 Transcriptional Network in Prostate Cancer Cancer Res., March 15, 2008; 68(6): 1988 - 1996. [Abstract] [Full Text] [PDF]

				J. Cao, C. Chiarelli, O. Richman, K. Zarrabi, P. Kozarekar, and S. Zucker Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer J. Biol. Chem., March 7, 2008; 283(10): 6232 - 6240. [Abstract] [Full Text] [PDF]

				T M Murphy, A S Perry, and M Lawler The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 11 - 25. [Abstract] [Full Text] [PDF]

				B. S. Taylor, M. Pal, J. Yu, B. Laxman, S. Kalyana-Sundaram, R. Zhao, A. Menon, J. T. Wei, A. I. Nesvizhskii, D. Ghosh, et al. Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression Mol. Cell. Proteomics, March 1, 2008; 7(3): 600 - 611. [Abstract] [Full Text] [PDF]

				J. Yu, J. Yu, D. R. Rhodes, S. A. Tomlins, X. Cao, G. Chen, R. Mehra, X. Wang, D. Ghosh, R. B. Shah, et al. A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome Cancer Res., November 15, 2007; 67(22): 10657 - 10663. [Abstract] [Full Text] [PDF]

				J. Villar, M. I. Arenas, C. M. MacCarthy, M. J. Blanquez, O. M. Tirado, and V. Notario PCPH/ENTPD5 Expression Enhances the Invasiveness of Human Prostate Cancer Cells by a Protein Kinase C{delta} Dependent Mechanism Cancer Res., November 15, 2007; 67(22): 10859 - 10868. [Abstract] [Full Text] [PDF]

				Q. Xu, P. K. Majumder, K. Ross, Y. Shim, T. R. Golub, M. Loda, and W. R. Sellers Identification of prostate cancer modifier pathways using parental strain expression mapping PNAS, November 6, 2007; 104(45): 17771 - 17776. [Abstract] [Full Text] [PDF]

				Y. P. Yu, G. Yu, G. Tseng, K. Cieply, J. Nelson, M. Defrances, R. Zarnegar, G. Michalopoulos, and J.-H. Luo Glutathione Peroxidase 3, Deleted or Methylated in Prostate Cancer, Suppresses Prostate Cancer Growth and Metastasis Cancer Res., September 1, 2007; 67(17): 8043 - 8050. [Abstract] [Full Text] [PDF]

				S. Y. Wong, H. Haack, J. L. Kissil, M. Barry, R. T. Bronson, S. S. Shen, C. A. Whittaker, D. Crowley, and R. O. Hynes Protein 4.1B suppresses prostate cancer progression and metastasis PNAS, July 31, 2007; 104(31): 12784 - 12789. [Abstract] [Full Text] [PDF]

				D. Huang, G. P. Casale, J. Tian, N. K. Wehbi, N. A. Abrahams, Z. Kaleem, L. M. Smith, S. L. Johansson, J. E. Elkahwaji, and G. P. Hemstreet III Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to {beta}-Catenin in Archived Prostate Specimens Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1371 - 1381. [Abstract] [Full Text] [PDF]

				S. C. Smith, G. Oxford, A. S. Baras, C. Owens, D. Havaleshko, D. L. Brautigan, M. K. Safo, and D. Theodorescu Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer Clin. Cancer Res., July 1, 2007; 13(13): 3803 - 3813. [Abstract] [Full Text] [PDF]

				B. Ren, Y. P. Yu, G. C. Tseng, C. Wu, K. Chen, U. N. Rao, J. Nelson, G. K. Michalopoulos, and J.-H. Luo Analysis of Integrin {alpha}7 Mutations in Prostate Cancer, Liver Cancer, Glioblastoma Multiforme, and Leiomyosarcoma J Natl Cancer Inst, June 6, 2007; 99(11): 868 - 880. [Abstract] [Full Text] [PDF]

				I. A. Mawji, C. D. Simpson, R. Hurren, M. Gronda, M. A. Williams, J. Filmus, J. Jonkman, R. S. Da Costa, B. C. Wilson, M. P. Thomas, et al. Critical Role for Fas-Associated Death Domain-Like Interleukin-1-Converting Enzyme-Like Inhibitory Protein in Anoikis Resistance and Distant Tumor Formation J Natl Cancer Inst, May 16, 2007; 99(10): 811 - 822. [Abstract] [Full Text] [PDF]

				R. S. Turley, E. C. Finger, N. Hempel, T. How, T. A. Fields, and G. C. Blobe The Type III Transforming Growth Factor-{beta} Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer Cancer Res., February 1, 2007; 67(3): 1090 - 1098. [Abstract] [Full Text] [PDF]

				Y. Li, J. Yang, J.-H. Luo, S. Dedhar, and Y. Liu Tubular Epithelial Cell Dedifferentiation Is Driven by the Helix-Loop-Helix Transcriptional Inhibitor Id1 J. Am. Soc. Nephrol., February 1, 2007; 18(2): 449 - 460. [Abstract] [Full Text] [PDF]

				R. J. Molinaro, B. K. Jha, K. Malathi, S. Varambally, A. M. Chinnaiyan, and R. H. Silverman Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells Nucleic Acids Res., December 2, 2006; 34(22): 6684 - 6695. [Abstract] [Full Text] [PDF]

				S. Chiosea, E. Jelezcova, U. Chandran, M. Acquafondata, T. McHale, R. W. Sobol, and R. Dhir Up-Regulation of Dicer, a Component of the MicroRNA Machinery, in Prostate Adenocarcinoma Am. J. Pathol., November 1, 2006; 169(5): 1812 - 1820. [Abstract] [Full Text] [PDF]

				R. L. Parr, G. D. Dakubo, K. A. Crandall, J. Maki, B. Reguly, A. Aguirre, R. Wittock, K. Robinson, J. S. Alexander, M. A. Birch-Machin, et al. Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant Histology J. Mol. Diagn., July 1, 2006; 8(3): 312 - 319. [Abstract] [Full Text] [PDF]

				B. S. Taylor, S. Varambally, and A. M. Chinnaiyan A Systems Approach to Model Metastatic Progression Cancer Res., June 1, 2006; 66(11): 5537 - 5539. [Abstract] [Full Text] [PDF]

				D. K. Vanaja, K. V. Ballman, B. W. Morlan, J. C. Cheville, R. M. Neumann, M. M. Lieber, D. J. Tindall, and C. Y.F. Young PDLIM4 Repression by Hypermethylation as a Potential Biomarker for Prostate Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1128 - 1136. [Abstract] [Full Text] [PDF]

				S. Nanni, C. Priolo, A. Grasselli, M. D'Eletto, R. Merola, F. Moretti, M. Gallucci, P. De Carli, S. Sentinelli, A. M. Cianciulli, et al. Epithelial-Restricted Gene Profile of Primary Cultures from Human Prostate Tumors: A Molecular Approach to Predict Clinical Behavior of Prostate Cancer Mol. Cancer Res., February 1, 2006; 4(2): 79 - 92. [Abstract] [Full Text] [PDF]

				G. Yu, G. C. Tseng, Y. P. Yu, T. Gavel, J. Nelson, A. Wells, G. Michalopoulos, D. Kokkinakis, and J.-H. Luo CSR1 Suppresses Tumor Growth and Metastasis of Prostate Cancer Am. J. Pathol., February 1, 2006; 168(2): 597 - 607. [Abstract] [Full Text] [PDF]

				D. C. Malins, N. K. Gilman, V. M. Green, T. M. Wheeler, E. A. Barker, and K. M. Anderson A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis PNAS, December 27, 2005; 102(52): 19093 - 19096. [Abstract] [Full Text] [PDF]

				S. A. Tomlins, D. R. Rhodes, S. Perner, S. M. Dhanasekaran, R. Mehra, X.-W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, et al. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer Science, October 28, 2005; 310(5748): 644 - 648. [Abstract] [Full Text] [PDF]

				H. Kim, J. Lapointe, G. Kaygusuz, D. E. Ong, C. Li, M. van de Rijn, J. D. Brooks, and J. R. Pollack The Retinoic Acid Synthesis Gene ALDH1a2 Is a Candidate Tumor Suppressor in Prostate Cancer Cancer Res., September 15, 2005; 65(18): 8118 - 8124. [Abstract] [Full Text] [PDF]

				I. U. Agoulnik, A. Vaid, W. E. Bingman III, H. Erdeme, A. Frolov, C. L. Smith, G. Ayala, M. M. Ittmann, and N. L. Weigel Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression Cancer Res., September 1, 2005; 65(17): 7959 - 7967. [Abstract] [Full Text] [PDF]

				Y. P. Yu, S. Paranjpe, J. Nelson, S. Finkelstein, B. Ren, D. Kokkinakis, G. Michalopoulos, and J.-H. Luo High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array Carcinogenesis, February 1, 2005; 26(2): 471 - 479. [Abstract] [Full Text] [PDF]